Have questions about the economic measures put in place to support businesses affected by the coronavirus (COVID-19)? Visit the Québec.ca.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. website.

Ouvrir ou fermer le menu de navigation

La page est en cours de chargement...  

Bannière Excellence Québec

Québec, an established industry

Québec has:

  • 696 companies actively involved in all stages of development of therapeutic products, medical technology and health-related digital products, from discovery to marketing.
  • Over 32,280 industrial jobs and almost as many jobs in research centres and related enterprises.

Many global leaders have chosen Québec as a business partner for their production activities. These include:

Québec’s life science ecosystem is booming:

  • In the last five years, private industrial projects carried out in Québec’s life sciences sector have totaled over $1 billion.

Recent investments

2017
  • Pharmascience.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. completed a project aimed at modernizing its Montréal facilities and boosting its production capacity. Estimated at $55.7 million, the project created 65 jobs.
2016
  • Nestle Skin Health invested $46 million to expand its medical division, Galderma.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité., in the Greater Montréal Area. The company expects to boost its plant’s production capacity and add 65 employees to the current tally of 315.
  • Medtronic.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. will move its ablation device production operations from California to its Montréal plant. This expansion project, assessed at $10.7 million, will create 47 jobs over the next three years.
2015
  • Medicago.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité., a major Canadian biotechnology company and global leader in vaccine and herbal treatment creation and production, chose to establish a new production facility in Québec City. The $245 million project will be completed by 2019.
  • Green Cross Biotherapeutics.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité., a South Korean biopharmaceutical company, has announced the construction of a plasma fractionation plant in Montréal. A total of $375 million will be invested in the project.

“North America is a huge market for intravenous immunoglobulin (IVIG), accounting for over 40% of the global plasma product market. Québec government authorities have been very helpful, bringing together strategic partners in Québec’s blood products sector and providing us the information we need to make sound investment decisions.

We’re eager to start producing safe, high-quality drugs in Québec.”

- Young-Ho Kim, President, Green Cross Biotherapeutics

2014
  • Servier.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité., the second largest French pharmaceutical laboratory, inaugurated a clinical research centre of excellence in Laval. The facility, which cost $16.3 million and covers an area of 2,780 m2, was built to help design and develop Servier’s international clinical research. Many major therapeutic areas will be studied at the lab, including cardiovascular disease, cancerology and neuropsychiatry.

Québec’s life sciences industry is:

Directory of Québec's key public research organizations and companies in the life sciences sector

Last update: June 26 2019

Ministère de l'Économie et de l'Innovation

© Gouvernement du Québec, 2020

Suivez-nous

  • LinkedIn
  • Youtube
  • Instagram